Novel pathways for fat burning that protects from high fat diet-induced metabolic
新型脂肪燃烧途径可防止高脂肪饮食引起的代谢
基本信息
- 批准号:8632675
- 负责人:
- 金额:$ 32.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-16 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipocytesAdipose tissueAdolescentAdoptionAdultAffectAnimalsBody fatBrown FatBurn injuryCardiovascular DiseasesCell physiologyChildCommunicationCountryCoupledDevelopmentDiabetes MellitusDietDiseaseEnergy MetabolismEnzymesEpidemicExhibitsFatty LiverFatty acid glycerol estersFoodGlucose IntoleranceGoalsHomeostasisHumanHydrogen PeroxideInsulin ResistanceIntakeIonsLeptinLife StyleLipolysisLiverManganese Superoxide DismutaseMediatingMetabolicMetabolic syndromeMetabolismMitochondriaMitochondrial MatrixMusNonesterified Fatty AcidsNutrientObesityOxidation-ReductionOxidative PhosphorylationOxidative StressPathogenesisPathway interactionsProductionProteinsPublic HealthRegulationResearchRisk FactorsRoleSkeletal MuscleSuperoxidesTestingTissuesUnited Statesblood glucose regulationcostfatty acid oxidationfeedingimprovedin vivoinsightinsulin secretioninsulin sensitivitylipid biosynthesismouse modelnoveloxidationpublic health relevanceresponsesedentarystatistics
项目摘要
PROJECT SUMMURY
Obesity rates are increasing in the United States, with recent statistics estimating more than 35.7% of
adults and 16.9% of children and adolescents are considered obese. Obesity is a risk factor for insulin
resistance, the metabolic syndrome and cardiovascular disease. Despite its public health importance,
the pathogenesis of obesity is not well understood. Increased oxidative stress in adipose tissue of
obese humans and animals in response to excess nutrient intake has been documented. However, the
role of adipose oxidative stress in the pathogenesis of obesity and its associated metabolic alterations
in not understood. To address this, we generated mice with increased superoxide production in
adipocytes through deletion of manganese superoxide dismutase (MnSOD), the sole enzyme
responsible for detoxifying superoxide to hydrogen peroxide in the mitochondrial matrix. The adipocyte-
specific MnSOD KO (AdSod2KO) mice are lean, have increased whole body fat oxidation and resist
diet-induced glucose intolerance, insulin resistance and hepatic steatosis. The overarching goal of this
proposal is to elucidate the mechanisms underlying enhanced fat oxidation and improved metabolic
homeostasis in response to HFD in AdSod2KO mice. This proposal has two specific aims: Specific
Aim 1 will identify the underlying mechanisms by which adipocyte MnSOD deletion and/or oxidative
stress enhanced whole body fat oxidation. Under this aim, we will first determine the contribution of
white and brown adipose tissue, liver and skeletal muscle in enhancing whole body fat oxidation, then
investigate whether the increase in whole body fat oxidation results from coupled or uncoupled
mitochondrial oxidation of fatty acid and finally identify redox-dependent mechanisms that can increase
fatty acid oxidation in white adipose tissue. Specific Aim 2 will determine tissue-specific mechanisms
by which MnSOD deletion and/or enhanced oxidative stress in mature adipocytes protects against
HFD-induced glucose intolerance, insulin resistance and hepatic steatosis in mice. Under this aim, we
will examine whether adipocyte MnSOD deletion affects lipolysis, determine if adipocyte MnSOD
deletion and/or oxidative stress enhance whole body insulin sensitivity during HFD and ¿-cell function
and identify known and unknown adipose-secreted factors that could mediate the beneficial systemic
effect on metabolism during HF feeding in AdSod2KO mice. These studies have high impact on obesity
research as it provides a new paradigm for adipose tissue oxidative stress and its impact on whole
body energy metabolism and insulin sensitivity. We believe that this research will provide new insights
on the redox-regulation of metabolism and could identify new targets that could be modulated to
enhance whole body fat oxidation and protects from the development of insulin resistance and diabetes
during obesity.
项目总结
美国的肥胖率正在上升,最近的统计数据估计超过 35.7%
成人和 16.9% 的儿童和青少年被认为肥胖 肥胖是胰岛素的危险因素。
抵抗力、代谢综合征和心血管疾病尽管其对公共卫生很重要,
肥胖的发病机制尚不清楚。
然而,肥胖的人类和动物对过量营养摄入的反应已有记录。
脂肪氧化应激在肥胖发病机制及其相关代谢改变中的作用
为了解决这个问题,我们培育了超氧化物产量增加的小鼠。
通过删除唯一的酶锰超氧化物歧化酶 (MnSOD) 来产生脂肪细胞
负责将线粒体基质中的超氧化物解毒为过氧化氢。
特定 MnSOD KO (AdSod2KO) 小鼠身材瘦削,全身脂肪氧化和抵抗力增强
饮食引起的葡萄糖不耐受、胰岛素抵抗和肝脂肪变性是其首要目标。
提案旨在阐明增强脂肪氧化和改善代谢的机制
AdSod2KO 小鼠对 HFD 的稳态反应 该提案有两个具体目标: 具体目标。
目标 1 将确定脂肪细胞 MnSOD 缺失和/或氧化的潜在机制
在此目标下,我们首先确定压力对全身脂肪氧化的贡献。
白色和棕色脂肪组织、肝脏和骨骼肌增强全身脂肪氧化,然后
研究全身脂肪氧化的增加是由耦合还是非耦合引起的
脂肪酸的线粒体氧化,并最终确定氧化还原依赖性机制,可以增加
白色脂肪组织中的脂肪酸氧化特定目标 2 将确定组织特异性机制。
成熟脂肪细胞中 MnSOD 缺失和/或氧化应激增强可以防止
HFD 诱导小鼠葡萄糖耐受不良、胰岛素抵抗和肝脂肪变性。
将检测脂肪细胞MnSOD缺失是否影响脂肪分解,确定脂肪细胞MnSOD是否
缺失和/或氧化应激可增强 HFD 和 ¿ 期间的全身胰岛素敏感性-细胞功能
并确定已知和未知的脂肪分泌因子,这些因子可以介导有益的系统性作用
HF 喂养期间 AdSod2KO 小鼠代谢的影响这些研究对肥胖有很大影响。
研究,因为它为脂肪组织氧化应激及其对整体的影响提供了新的范例
我们相信这项研究将提供新的见解。
代谢的氧化还原调节,并可以确定可以调节的新目标
增强全身脂肪氧化并防止胰岛素抵抗和糖尿病的发生
肥胖期间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sihem Boudina其他文献
Sihem Boudina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sihem Boudina', 18)}}的其他基金
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
靶向 EphB 受体的小分子拮抗剂用于治疗非酒精性脂肪性肝炎 (NASH)
- 批准号:
10618311 - 财政年份:2021
- 资助金额:
$ 32.41万 - 项目类别:
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
靶向 EphB 受体的小分子拮抗剂用于治疗非酒精性脂肪性肝炎 (NASH)
- 批准号:
10216710 - 财政年份:2021
- 资助金额:
$ 32.41万 - 项目类别:
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
靶向 EphB 受体的小分子拮抗剂用于治疗非酒精性脂肪性肝炎 (NASH)
- 批准号:
10455535 - 财政年份:2021
- 资助金额:
$ 32.41万 - 项目类别:
The Role of PRDM16 in Cardiac Development and Cardiomyopathy
PRDM16 在心脏发育和心肌病中的作用
- 批准号:
10408821 - 财政年份:2020
- 资助金额:
$ 32.41万 - 项目类别:
The Role of PRDM16 in Cardiac Development and Cardiomyopathy
PRDM16 在心脏发育和心肌病中的作用
- 批准号:
10212450 - 财政年份:2020
- 资助金额:
$ 32.41万 - 项目类别:
The Role of PRDM16 in Cardiac Development and Cardiomyopathy
PRDM16 在心脏发育和心肌病中的作用
- 批准号:
10058736 - 财政年份:2020
- 资助金额:
$ 32.41万 - 项目类别:
The Role of PRDM16 in Cardiac Development and Cardiomyopathy
PRDM16 在心脏发育和心肌病中的作用
- 批准号:
10627955 - 财政年份:2020
- 资助金额:
$ 32.41万 - 项目类别:
Novel pathways for fat burning that protects from high fat diet-induced metabolic
新型脂肪燃烧途径可防止高脂肪饮食引起的代谢
- 批准号:
8923259 - 财政年份:2013
- 资助金额:
$ 32.41万 - 项目类别:
Novel pathways for fat burning that protects from high fat diet-induced metabolic
新型脂肪燃烧途径可防止高脂肪饮食引起的代谢
- 批准号:
9133360 - 财政年份:2013
- 资助金额:
$ 32.41万 - 项目类别:
相似国自然基金
巨噬细胞GP73-CXCL5调节脂肪组织适应性产热的机制研究
- 批准号:32300573
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
不同脂肪组织及其驻留巨噬细胞调控小鼠禁食稳态的系统研究
- 批准号:32301235
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
有氧康复运动抑制心外膜脂肪组织Th17细胞分化改善HFpEF所致心房颤动实验研究
- 批准号:82372581
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
MYO9B缺失调控脂肪组织巨噬细胞代谢重编程促进肥胖相关胰岛素抵抗的机制研究
- 批准号:82300948
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Them1 Inhibitors for the Management of Non-Alcoholic Fatty Liver Disease
Them1 治疗非酒精性脂肪肝的抑制剂
- 批准号:
10666090 - 财政年份:2023
- 资助金额:
$ 32.41万 - 项目类别:
PDGFRB Signaling in Progressive Skin Disease
进行性皮肤病中的 PDGFRB 信号传导
- 批准号:
10583948 - 财政年份:2023
- 资助金额:
$ 32.41万 - 项目类别:
Mechanical properties of adipose tissue and its effect on breast cancer
脂肪组织的力学特性及其对乳腺癌的影响
- 批准号:
10737165 - 财政年份:2023
- 资助金额:
$ 32.41万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10703523 - 财政年份:2023
- 资助金额:
$ 32.41万 - 项目类别:
Modifying adipocyte and pre-adipocyte cell fate in fibroadipose tissue of secondary lymphedema
改变继发性淋巴水肿纤维脂肪组织中的脂肪细胞和前脂肪细胞细胞命运
- 批准号:
10571049 - 财政年份:2023
- 资助金额:
$ 32.41万 - 项目类别: